Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 982 to 1031 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5a (eif-5a) (eif-4d) (rev- binding factor). [source:swissprot;acc:p10159]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1612\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6212.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6655.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07116\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
506\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3893.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4450.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
evolutionarily conserved g-patch domain containing. [source:refseq;acc:nm\_018025]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1652\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5944.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6358.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
evolutionarily conserved signaling intermediate in toll pathway; ecsit. [source:refseq;acc:nm\_016581]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1537\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6184.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6637.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07328\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component exo70. [source:swissprot;acc:q9upt5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2781\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec10 (hsec10). [source:swissprot;acc:o00471]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1438\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6721.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7238.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07693\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec15a. [source:swissprot;acc:q8tag9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1068\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6201.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6774.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09237\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec15b. [source:swissprot;acc:q9y2d4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1083\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6213.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6785.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09198\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec3 (bm-012). [source:swissprot;acc:q9nv70]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2048\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6036.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6379.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05678\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec5. [source:swissprot;acc:q96kp1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
286\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23316\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19288.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20878\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec6. [source:swissprot;acc:o60645]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2135\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7387.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7785.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05388\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exocyst complex component sec8. [source:swissprot;acc:q96a65]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1311\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6221.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6727.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08142\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exonuclease 1 isoform b; rad2 nuclease family member, homolog of s. cerevisiae exonuclease 1. [source:refseq;acc:nm\_006027]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2170\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5825.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6126.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05169\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2594\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4921.84\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5005.06\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01691\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2595\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2593\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2596\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
exportin 1; exportin-1 (required for chromosome region maintenance); exportin 1 (crm1, yeast, homolog); crm1, yeast, homolog. [source:refseq;acc:nm\_003400]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
826\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5195.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5750.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10678\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eyes absent homolog 1. [source:swissprot;acc:q99502]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2268\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5785.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6051.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eyes absent homolog 2. [source:swissprot;acc:o00167]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2299\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5786.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6050.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04572\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eyes absent homolog 3. [source:swissprot;acc:q99504]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2274\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5779.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6044.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04587\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eyes absent homolog 4. [source:swissprot;acc:o95677]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2296\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5784.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6049.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04582\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ezrin-binding partner pace-1 isoform 1. [source:refseq;acc:nm\_020423]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3228\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
f-actin capping protein alpha-1 subunit (capz alpha-1). [source:swissprot;acc:p52907]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1490\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6340.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6815.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
f-actin capping protein alpha-2 subunit (capz alpha-2). [source:swissprot;acc:p47755]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1497\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6339.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6812.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07467\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
f-actin capping protein alpha-3 subunit (capz alpha-3) (germ cell- specific protein 3). [source:swissprot;acc:q96kx2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1681\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6304.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6740.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06914\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
f-actin capping protein beta subunit (capz beta). [source:swissprot;acc:p47756]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1682\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
f-box protein fbw7 isoform 2; archipelago, drosophila, homolog of; f-box protein fbw7; f-box protein sel-10; homolog of c elegans sel-10. [source:refseq;acc:nm\_018315]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
100\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2353.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3225.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3705\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fad synthetase. [source:refseq;acc:nm\_025207]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1841\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3591.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3375.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
far upstream element-binding protein; far upstream element binding protein; fuse-binding protein. [source:refseq;acc:nm\_003902]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2092\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5817.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6138.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05525\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
farnesyl pyrophosphate synthetase (fpp synthetase) (fps) (farnesyl diphosphate synthetase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10)]. [source:swissprot;acc:p14324]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1180\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fas apoptotic inhibitory molecule. [source:refseq;acc:nm\_018147]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2307\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5666.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5923.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04528\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2370\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5265.95\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5492.28\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04298\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid desaturase 2; linoleoyl-coa desaturase (delta-6-desaturase)-like 2; delta-6 fatty acid desaturase. [source:refseq;acc:nm\_004265]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2369\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid desaturase 3; linoleoyl-coa desaturase (delta-6-desaturase)-like 3; delta-6 fatty acid desaturase. [source:refseq;acc:nm\_021727]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2367\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid hydroxylase domain containing 1. [source:refseq;acc:nm\_024306]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2204\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5076.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5326.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04916\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid-binding protein, adipocyte (afabp) (adipocyte lipid-binding protein) (albp) (a-fabp). [source:swissprot;acc:p15090]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1665\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5791.14\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6193.02\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0694\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid-binding protein, brain (b-fabp) (brain lipid-binding protein) (blbp) (mammary derived growth inhibitor related). [source:swissprot;acc:o15540]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1667\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid-binding protein, epidermal (e-fabp) (psoriasis-associated fatty acid-binding protein homolog) (pa-fabp). [source:swissprot;acc:q01469]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1666\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fatty acid-binding protein, heart (h-fabp) (muscle fatty acid-binding protein) (m-fabp) (mammary-derived growth inhibitor) (mdgi). [source:swissprot;acc:p05413]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1674\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fatty aldehyde dehydrogenase (ec 1.2.1.3) (aldehyde dehydrogenase, microsomal) (aldh class 3). [source:swissprot;acc:p51648]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3181\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fatty-acid amide hydrolase (ec 3.1.-.-) (oleamide hydrolase) (anandamide amidohydrolase). [source:swissprot;acc:o00519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1951\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5888.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06073\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
403\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ferritin heavy chain (ferritin h subunit). [source:swissprot;acc:p02794]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
620\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6227.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7012.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ferritin heavy polypeptide-like 17. [source:swissprot;acc:q9bxu8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
635\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6228.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12595\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ferritin light chain (ferritin l subunit). [source:swissprot;acc:p02792]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
633\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ferrochelatase, mitochondrial precursor (ec 4.99.1.1) (protoheme ferro-lyase) (heme synthetase). [source:swissprot;acc:p22830]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3185\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fetal brain protein 239 (239fb). [source:swissprot;acc:q15777]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1053\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fibrillarin (34 kda nucleolar scleroderma antigen). [source:swissprot;acc:p22087]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
646\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4019.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4522.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12506\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fibrillin 1 precursor. [source:swissprot;acc:p35555]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2844\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/